Back to RhumbLine Advisers RhumbLine Advisers

VIVOVIVO

Showing 0 of 18 quarters

Position history for RhumbLine AdvisersRhumbLine Advisers's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, RhumbLine Advisers held 96,989 shares of VIVO (Meridian Bioscience), worth $3.2M. RhumbLine Advisers' 13F filings listed VIVO from Q4 2018 to Q4 2022, 17 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used